Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

Why Worthington Steel Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket

Shares of Worthington Steel, Inc. (NYSE:WS) rose sharply in today's pre-market trading as the company reported stronger-than-expected financial results for the fourth quarter.

Benzinga

Purdue Pharma plan moves forward despite challenge from opioid victim

Plaintiff says company’s bid to exit bankruptcy omits US government plan to seize $225m that should go to victims

The Guardian - US

Louisiana files lawsuits alleging pharmaceutical giant CVS deceived customers in text messages

Louisiana accused pharmaceutical giant CVS of using its dominant market position to abuse customer information, drive up drug costs and unfairly undermine independent pharmacies

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

RFK Jr grilled on vaccine policies and healthcare fraud in bruising House hearing

US health secretary faced hours of questioning over budget cuts and accusations he lied to senators

The Guardian - US

HIMS Crashes On Novo GLP-1 Fallout: Buy The Dip Or Bail?

Telehealth darling Hims Hers Health Inc (NYSE:HIMS) got slapped with a 34% stock crash on Monday. Novo Nordisk A/S (NYSE:NVO) ended their relationship – and it wasn't amicable.

Benzinga

Why Did Novo Nordisk Pull the Plug on Hims Collaboration?

Novo Nordisk ended its partnership with Hims & Hers on 23 June 2025, accusing the telehealth firm of selling unsafe, unapproved Wegovy knock-offs. Hims' stock tanked, and legal risks loom.

International Business Times UK

Why Nektar Therapeutics Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket

Shares of Nektar Therapeutics (NASDAQ:NKTR) rose sharply in today's pre-market trading after the company announced it will release top-line data from the 16-week induction period in the ongoing global Phase 2b REZOLVE-AD clinical trial of investigational rezpegaldesleukin on June 24, 2025.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Hims CEO Slams Novo Nordisk For 'Anticompetitive Demands' After Ozempic Maker Abruptly Ends Partnership: 'We Refuse To Be Strong-Armed'

Hims Hers Health Inc. (NYSE:HIMS), CEO Andrew Dudum, has accused Novo Nordisk of exerting anticompetitive pressure to prioritize its weight-loss drug Wegovy over patient needs after the abrupt termination of its partnership with a pharmaceutical giant.

Benzinga

Ocugen (OCGN) Shares Slide Following Merger Agreement: What's Going On?

Shares of Ocugen Inc (NASDAQ:OCGN) are trading lower by more than 8% Monday afternoon. The company earlier announced a definitive agreement to merge its subsidiary OrthoCellix with Carisma Therapeutics in an all-stock deal.

Benzinga

CorMedix Stock Hits New 52-Week High On Updated Guidance: The Details

CorMedix Inc (NASDAQ:CRMD) shares are hitting new 52-week highs on Monday after the company raised its sales guidance for the second quarter.

Benzinga

Purdue Pharma's $7B opioid settlement plan could get votes from victims and cities

A judge could decide Friday whether to advance OxyContin maker Purdue Pharma's $7 billion-plus plan to settle thousands of lawsuits over the toll of opioids

The Independent UK

A judge could advance Purdue Pharma's $7B opioid settlement after all 50 states back it

A judge is being asked to clear the way for local governments and individual victims to vote on OxyContin maker Purdue Pharma’s plan to settle thousands of lawsuits over the toll of opioids

The Independent UK

FDA to offer faster drug reviews to companies promoting 'national priorities'

The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump administration priorities for Americans' health

The Independent UK

Purdue Pharma to pay $7.4 billion in opioid lawsuit settlement

Besides the hefty financial reward, the settlement also ends the Sackler family’s ownership of Purdue Pharma and their ability to sell opioids in the U.S.

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Second patient death reported with gene therapy for muscular dystrophy

Shares of Sarepta Therapeutics have plunged again after the drugmaker reported a second death in connection with its gene therapy for muscular dystrophy

Al Jazeera

Purdue Pharma $7.4bn opioid settlement wins broad support from US states

The suit, brought by 55 attorneys general, will help compensate victims and fund addiction treatment programmes.

The Guardian - UK

PPE from company linked to Mone did not meet required safety standards, court told

Department of Health wants refund of £122m spent on unused surgical gowns, but PPE Medpro says it went into contract with ‘eyes wide open’

The National (Scotland)

Suspected drug deaths in Scotland up by a third in three months, figures show

SUSPECTED drug deaths in Scotland have risen by a third in the first three months of this year, figures have revealed ...

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Top RFK Jr. aide attacks US health system while running company that promotes wellness alternatives

A top aide to Health Secretary Robert F

Evening Standard

Rachel Reeves to announce £86bn for science and technology in spending review

Regions will be handed up to £500 million with local leaders given powers to decide how investment is targeted in their communities.

International Business Times UK

Can Birth Control Give You Brain Tumors? These 400 Women Say The Pfizer Shot Did

Hundreds of women allege Pfizer's contraceptive injection caused tumors, accusing the company of ignoring known dangers and insufficient safety warnings.

The Guardian - US

23andMe back on the auction block after former CEO makes 11th-hour bid

Anne Wojcicki, ex-CEO of the DNA testing firm, put in a $305m bid, upending Regeneron’s $256m agreement

Bored Panda

26 Examples Of Packaging So Misleading, It’s Basically A Scam, As Shared On This Online Community

These packages look like they were intentionally designed to lure away our money.

International Business Times

At No Cost to Federal Government a Lifeline for America's Communities

At its heart, 340B is about getting medicine—and the healthcare services needed to ensure their safe and effective use—to people who otherwise might go without it.

Evening Standard

Drug maker Indivior joins the flight from London share listings

Pharmaceuticals company said most of its product sales and shareholders are US based

1 … 21 22 23 24

People

Alexandria OcasioCortez

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Scottish Government

the Department of Justice

Food and Drug Administration

337 stories

PPE Medpro

245 stories

the London Stock Exchange

187 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.